You really have no basis for that statement. Do you really want to hang your hat on ONE and ONLY ONE trial whose progress won't be disclosed for at least another year? Given the Phase II fiasco, they need to have Plan B in place. How do you know betabodies is not in a preclinical collaboration? What makes you think that betabodies won't be better than the current bavi?
News 
Market Data 
Discover 
